[1]
L. Y. Rodríguez-Tanta, E. Cachay Rojas, F. Fiestas Saldarriaga, G. Alva Lozada, P. Fernández-Rojas, and R. Delgado-Escalante, “Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital”, Rev Peru Med Exp Salud Publica, vol. 40, no. 1, pp. 16–24, Mar. 2023, doi: 10.17843/rpmesp.2023.401.11563.